Local News

Nascent Pharmaceuticals Adds Board Member

Posted Updated

RESEARCH TRIANGLE PARK, N.C. — Joanna Horobin, president and chief executive officer of Syndax Pharmaceuticals, has joined the board of directors at RTP-based

Nascent Pharmaceuticals


Nascent is focused on development of ophthalmology and oncology drugs. It is currently seeking a business development and commercialization partner for its lead drug to treat dry eye.

Syndax is a startup focused on treatment of cancer. Before joining that company, Horobin was entrepreneur in residence at MPM Capital, an investor in life sciences. She has also worked for several biotechnology firms.

Copyright 2024 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.